Bioneer Corporation (KOSDAQ:064550)
South Korea · Delayed Price · Currency is KRW 8,260.00
-270.00 (-3.17%)
Sep 22, 2026, 3:30 PM KST
Bioneer Market Cap
Bioneer has a market cap or net worth of 220.16 billion as of September 22, 2026. Its market cap has decreased by -42.75% in one year.
Market Cap
220.16B
Enterprise Value
254.03B
Revenue
345.88B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,260.00
ChartMarket Cap Chart
Since December 29, 2005, Bioneer's market cap has increased from 157.77B to 220.16B, an increase of 39.55%. That is a compound annual growth rate of 1.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 220.16B | -33.10% |
| Dec 30, 2025 | 329.08B | -32.36% |
| Dec 30, 2024 | 486.52B | -43.39% |
| Dec 28, 2023 | 859.48B | 13.27% |
| Dec 29, 2022 | 758.82B | -39.51% |
| Dec 30, 2021 | 1.25T | 181.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbClon | 390.26B |
| Proteina | 386.78B |
| MEDIPOST | 346.69B |
| SillaJen | 305.51B |
| Genomictree | 293.56B |
| GC Cell | 220.75B |
| NeoImmuneTech | 195.56B |
| HLB Therapeutics | 169.05B |